Hoy también se ha sabido que :
****************************
Malignant Pleural Mesothelioma (MPM) . Yondelis . ( Actualización ) :
ATREUS - Phase II Study on the Activity of Trabectedin in Patients With Malignant Pleural Mesothelioma (MPM) (ATREUS) .
Sponsor : Mario Negri Institute for Pharmacological Research.
Collaborator : PharmaMar.
Information provided by (Responsible Party) : Mario Negri Institute for Pharmacological Research.
Study NCT02194231
on Date: March 27, 2018 (v5).
Study Identification
Unique Protocol IDn : IRFMN-MPM-6077
Brief Title: ATREUS - Phase II Study on the Activity of Trabectedin in Patients With Malignant Pleural Mesothelioma (MPM) (ATREUS).
Official Title: ATREUS Trial - A Phase II Study on the Activity of Trabectedin of Pretreated Epithelioid or Biphasic / Sarcomatoid Malignant Pleural Mesothelioma(MPM).
Secondary IDs: 2011-006330-16 [EudraCT Number]
Study Status
Record Verification : March 2018
Overall Status : Recruiting
Study Start : July 2013.
Primary Completion : November 2018 [Anticipated].
Study Completion : November 2018 [Anticipated].